Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-13-003960
Filing Date
2013-01-22
Accepted
2013-01-22 21:29:55
Documents
1
Period of Report
2013-01-17

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 11624
  Complete submission text file 0001104659-13-003960.txt   13232
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 1609 NEW YORK NY 10170
Business Address
Denoyer Bernard (Reporting) CIK: 0001397636 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35268 | Film No.: 13541441